ConductScience.org, home

Library / Genes

BCL2L11: BCL2 like 11

1 protein, 67 patents, 0 drugs, 0 trials, 7,243 NIH grants and 15,450 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolBCL2L11HGNC
NameBCL2 like 11HGNC
NCBI Gene ID10018NCBI Gene
HGNC IDHGNC:994HGNC
EnsemblENSG00000153094NCBI Gene
AliasesBAM, BIM, BOD, BimEL, BimL, BimSNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
O43521Bcl-2-like protein 1119845Ensembl, GeneID, HGNCUniProt

Patents 67

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4641202 A22025-10-295874O43521Espacenet
US 12287338 B22025-04-295O43521Espacenet
JP 2025062604 A2025-04-148791O43521Espacenet
KR 1020250017231 A2025-02-045874O43521Espacenet
JP 2024123008 A2024-09-105054O43521Espacenet
US 11708396 B22023-07-251469O43521Espacenet
US 11656230 B22023-05-2317O43521Espacenet
US 11446398 B22022-09-208791O43521Espacenet
JP 2022524081 A2022-04-27111762O43521Espacenet
US 10918740 B22021-02-167049O43521Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 7243

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant1882,025NIH's project files
P30CA008748Cancer Center Support Grant802,025NIH's project files
P30CA016059Massey Cancer Center - Cancer Center Support Grant422,025NIH's project files
P30CA047904Cancer Center Support Grant372,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant342,025NIH's project files
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant322,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)302,025NIH's project files
P01CA066996Development of Novel Therapeutic Strategies in Human Leukemias282,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant262,025NIH's project files
P30CA016058Cancer Center Support Grant242,025NIH's project files

Papers 15450

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42818321PubTator, text miningPubMed
42800027PubTator, text miningPubMed
42776739PubTator, text miningPubMed
42737771PubTator, text miningPubMed
42732692PubTator, text miningPubMed
42717786PubTator, text miningPubMed
42696608PubTator, text miningPubMed
42693245PubTator, text miningPubMed
42647134PubTator, text miningPubMed
42621724PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license